<DOC>
	<DOCNO>NCT00003627</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy radiation therapy may kill tumor cell allow doctor preserve part body cancer start . It yet know whether radiation therapy combination chemotherapy effective radiation therapy alone treat cancer oropharynx hypopharynx surgically remove . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy plus cisplatin fluorouracil radiation therapy alone treat patient advanced cancer oropharynx hypopharynx surgically remove .</brief_summary>
	<brief_title>Radiation Therapy With Without Combination Chemotherapy Treating Patients With Advanced Cancer Oropharynx Hypopharynx</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival survival without relapse 1 , 3 , 5 year patient squamous cell cancer oropharynx hypopharynx treatment twice day radiotherapy without cisplatin fluorouracil . - Compare presence distant metastases 1 , 3 , 5 year patient treatment . - Compare local control duration control patient treatment . - Compare clinical change histological change 6 month patient treatment . - Determine rate complete response patient treatment . - Determine early late toxic effect regimens patient . - Determine quality life patient . - Determine pharmacokinetics fluorouracil tolerability regimen patient . OUTLINE : This randomize , multicenter study . Patients stratify accord center primary site disease ( oropharynx v hypopharynx ) Patients randomize one two treatment arm . - Arm I : Patients undergo radiotherapy twice day , 6 hour apart , 5 day week , 7 week . - Arm II : Patients undergo radiotherapy arm I , plus concurrent chemotherapy consist cisplatin IV day 1 fluorouracil continuous infusion 24 hour day 1-5 . Courses repeat every 3 week 3 course . Patients follow every month 1 year , every 2-3 month 2 year , every 6 month least 2 year . PROJECTED ACCRUAL : A total 160 patient ( 80/arm ) accrue study within 4.5 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven squamous cell cancer oropharynx hypopharynx T4 nonresectable OR T3 extend oropharynx hypopharynx nonresectable N03 ( stage III IV ) No distant metastasis PATIENT CHARACTERISTICS : Age : 18 70 Performance status : Karnofsky 70100 % Life expectancy : Greater 3 month Hematopoietic : Neutrophil count least 2000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.25 time upper limit normal ( ULN ) Transaminases great 2.5 time ULN Renal : Creatinine great 1.25 time ULN Cardiovascular : No severe cardiac disease Other : No prior malignancy except basal cell skin cancer No uncontrolled infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No concurrent antineoplastic therapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : No prior surgery ( except biopsy adenectomy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
</DOC>